Institute for the History of Medicine and Medical Ethics, Research Unit Ethics, University Hospital of Cologne, Cologne, Germany.
Prog Neurobiol. 2013 Nov;110:74-88. doi: 10.1016/j.pneurobio.2013.04.002. Epub 2013 Apr 27.
Deep brain stimulation (DBS) has proven to be a successful therapeutic approach in several patients with movement disorders such as Parkinson's disease and dystonia. Hitherto its application was mainly restricted to advanced disease patients resistant to medication or with severe treatment side effects. However, there is now growing interest in earlier application of DBS, aimed at improving clinical outcomes, quality of life, and avoiding psychosocial consequences of chronic disease-related impairments. We address the clinical and ethical aspects of two "early" uses of DBS, (1) DBS early in the course of the disease, and (2) DBS early in life (i.e. in children). Possible benefits, risks and burdens are discussed and thoroughly considered. Further research is needed to obtain a careful balance between exposing vulnerable patients to potential severe surgical risks and excluding them from a potentially good outcome.
脑深部电刺激(DBS)已被证明对多种运动障碍疾病(如帕金森病和肌张力障碍)患者具有成功的治疗作用。迄今为止,其应用主要局限于对药物治疗有抵抗或出现严重治疗副作用的晚期疾病患者。然而,现在人们对 DBS 的早期应用越来越感兴趣,旨在改善临床结局、生活质量,并避免与慢性疾病相关损害有关的心理社会后果。我们探讨了 DBS 的两种“早期”应用的临床和伦理问题,(1)疾病早期进行 DBS,以及(2)生命早期(即儿童期)进行 DBS。讨论并充分考虑了可能的益处、风险和负担。需要进一步研究,以在将易受伤害的患者暴露于潜在严重手术风险与将他们排除在可能的良好结果之外之间取得谨慎的平衡。